HMGB1 and Hyperbilirubinemia: It may be hypothesized that the increased inflammation triggered by HMGB1 and/or TNF-α could be at least partly responsible for intrahepatic cholestasis and could further lead to hyperbilirubinemia in patients with ACLF.